Mesenchymal stromal cells for COVID-19: A living systematic review protocol

Gabriel Rada, Javiera Corbalán, Patricio Rojas, COVID-19 L·OVE Working Group
doi: https://doi.org/10.1101/2020.04.13.20064162

Article Information

doi 
https://doi.org/10.1101/2020.04.13.20064162
History 
  • April 18, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Gabriel Rada1,2,3,*,
  2. Javiera Corbalán4,
  3. Patricio Rojas5,6,
  4. COVID-19 L·OVE Working Group
  1. 1Fundación Epistemonikos, Santiago, Chile
  2. 2UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile
  3. 3Internal Medicine Department, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
  4. 4Institute of Public Health, Faculty of Medicine, Universidad Austral de Chile
  5. 5Hematology and Oncology Department, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
  6. 6University Hospital, Cleveland Medical Center, Ohio, United States
  1. ↵*Corresponding author:
    Gabriel Rada, Email address: radagabriel{at}epistemonikos.org, Postal address: Holanda 895, Providencia, Santiago, Chile.
Back to top
Posted April 18, 2020.
Download PDF
Data/Code
Email
Mesenchymal stromal cells for COVID-19: A living systematic review protocol
Gabriel Rada, Javiera Corbalán, Patricio Rojas, COVID-19 L·OVE Working Group
medRxiv 2020.04.13.20064162; doi: https://doi.org/10.1101/2020.04.13.20064162
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area